Vicore Pharma starts Phase I trial of angiotensin II type 2 receptor agonist
The drug is available orally with target engagement and anti-fibrotic effects in human fibrotic lung and kidney tissue.
Sweden
Latest in
Sweden
RhoVac’s Phase IIb prostate cancer trial fails to meet primary endpoint
No unanticipated adverse events were reported in the trial with end trial data validating the expected safety of RV001.
Enrolment challenges persist in eating disorder clinical trials despite diagnosis increase
Social media, earlier help-seeking, and worsening of symptoms due to lockdowns contribute to increase in eating disorder diagnosis.
By
LINK Medical and Viedoc partner for programme to boost trial efficiency
The collaboration aids in uninterrupted interchange of experience, needs, and ideas and new feature testing.
Oncorena begins Phase I/II trial in advanced kidney cancer
The trial will enrol up to 40 subjects and could be extended to include participants from other European nations.
Sobi and Selecta Biosciences complete enrolment for gout therapy trial
The DISSOLVE I study will assess the efficacy and safety of SEL-212 to treat chronic refractory gout.
InDex begins enrolment in trial of cobitolimod to treat ulcerative colitis
The Phase III CONCLUDE clinical trial will recruit nearly 440 patients at several clinics in more than 30 countries.
Trialbee unveils centralised clinical trial patient recruitment platform
Trialbee Honey helps in recruiting and engaging qualified patients for a clinical study.